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1684-1182/Copyright ª 2015, TaiwanBackground/Purpose: Leishmania (L.) tropica is the causative agent of different forms of human
leishmaniasis.There is little informationabout the roleofLeishmania-specificantibodies in the im-
mune response against L. tropica infection. The aim of this study is to evaluate the role of Leish-
mania-specific antibodies and their immunoglobulin G (IgG) isotypes in L. tropica infection.
Methods: L. tropica at two different doses (high dose, 106 parasites/mouse and low dose, 103 par-
asites/mouse)were used for infection of BALB/cmice. BALB/cmice infectedwith Leishmaniama-
jor were used for comparison. Anti-Leishmania antibodies of the IgG1 and IgG2a isotypes were
assayed by enzyme-linked immunosorbent assay.
Results: Our data showed that (1) a higher parasite dose results in higher levels of antibody. (2) L.
tropica infection results in a lower IgG1 antibody response, comparedwith L.major infection. (3)
The IgG2a/IgG1 antibody response in L. tropica infection is higher than that in L. major infection.
Conclusion: A higher IgG2a/IgG1 ratio is associatedwith protective immune response in L. tropica
infection. These data can help to approach the complex profile of immunity against L. tropica
infection.
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Leishmaniasis is a disease resulting from infection by pro-
tozoan parasites of the genus Leishmania (L.), which can
affect man and several species of animals. Leishmania
tropica is the causative agent of different forms of human
leishmaniasis, anthroponotic and viscerotropic diseases,
and a few cases of visceral leishmaniasis in many parts of
the world including Iran. Leishmania major is a major
causative agent of cutaneous leishmaniasis.1
With regard to Leishmania parasites, it is generally
accepted that protection from related diseases is associ-
ated with cellular immune response. In fact, it was re-
ported that removal of B cells or antibodies profoundly
alters the course and outcome of infection within genet-
ically susceptible and resistant mouse strains.2 Antibodies
are an important component of immune response against
pathogens. Antibodies have evolved into classes and sub-
classes with specific assigned functions such as cytotox-
icity, phagocytosis, and release of inflammatory
mediators.3 Both detrimental and beneficial roles for host
have been reported for Leishmania-specific antibodies.
With regard to detrimental roles, it has been reported that
B cells and/or antibodies are required for disease sus-
ceptibility in BALB/c mice.4 It has also been shown that
these antibodies contribute to the progression of Leish-
mania disease through the induction of interleukin-10 (IL-
10) production from macrophages.5 The ligation of
macrophage Fcg receptors (FcgR) promoted the produc-
tion of IL-10 and inhibited the secretion of IL-12. The
implication from these studies is that immunoglobulin G
(IgG) itself may be an important promoter of the Th2-type
immune response.6 The detrimental role of these anti-
bodies was also reported in another study on leishmaniasis
in both experimental animals infected with L. major and
humans with visceral leishmaniasis.5 It has been shown
that BALB/c mice lacking the common g-chain of the Fc
receptor can control L. major infection and totally resolve
cutaneous lesions.7 With regard to the beneficial role of
antibodies, immune immunoglobulin G (IgG) production
and engagement of dendritic cell FcgR are required for
the timely development of Th1/Tc1-dependent immunity
and control of experimental cutaneous leishmaniasis in
mice.8 The IgG subclasses in BALB/c mice include IgG1,
IgG2a, IgG2b, and IgG3.9e12 The IgG subclass expression is
influenced by multiple factors, including the prevailing
cytokine environment. It is known that interferon-g (as a
Th1 cytokine) and IL-4 (as a Th2 cytokine) induce isotype
switching to IgG2a and IgG1, respectively.13,14 These two
IgG isotypes have been used in many studies as surrogate
markers of Th1 and Th2 responses against Leishmania and
other infections.15,16 Many reports show that during
Leishmania infections, higher amounts of Leishmania-
specific antibodies of the IgG1 isotype in comparison with
IgG2a are associated with disease progression, and higher
amounts of Leishmania-specific antibodies of the IgG2a
isotype in comparison with IgG1 are associated with pro-
tection against the disease.17e23 It is crucial to know
whether all antibody responses or only certain isotypes are
pathogenic, to tailor these responses to the benefit of the
host.24Please cite this article in press as: Rostamian M, et al., Lower levels
immunity against Leishmania tropica infection in BALB/c mice, Jou
dx.doi.org/10.1016/j.jmii.2015.05.007The dose of Leishmania parasites used for inoculation is
an important factor determining the course and outcome of
disease in murine models of leishmaniasis.25 A low dose of
100 parasites results in protective immunity against the
parasite,17 whereas a high dose of 105e107 parasites results
in progressive disease in BALB/c mice.25 Therefore, the
infective dose of parasite may acts as a variable in the in-
duction of antibody response against Leishmania parasites.
L. tropica and L. major differ from each other with re-
gard to pathogenicity in experimental models. In BALB/c
mice, L. major produces rapidly progressing, nonhealing,
and destructive lesions, whereas lesions of L. tropica are
nonulcerative and eventually controlled.26,27 Although the
immune response against L. major infection has been
studied in-depth,28 there is limited information about the
immunology of L. tropica infection. Thus, experimental
models of L. tropica infection can help in increasing the
knowledge about this infection.
The aim of this study is to evaluate the role of Leish-
mania-specific antibodies and their IgG isotypes in L.
tropica infection. For this purpose, we determined the ki-
netics of production of Leishmania-specific antibodies
during the course of L. tropica infection in BALB/c mice.
Two different doses of parasites [high dose (106 parasites/
mouse) and low dose (103 parasites/mouse)] were used for
inoculation. L. major infection in BALB/c mice was used as
a well-defined model to validate our assay variables and the
L. major data were compared with those of L. tropica.
Methods
Parasite and antigen
The L. tropica strain MHOM/AF/88/KK27 isolated from a
patient with cutaneous leishmaniasis in Afghanistan was
kindly donated by Dr D. Sacks (Laboratory of Parasitic Dis-
eases, National Institutes of Health, Bethesda, MD, USA).
The L. major strain MRHO/IR/75/ER isolate from Iran was a
gift from Dr M. Mohebali (School of Public Health, Tehran
University of Medical Sciences, Tehran, Iran). Procedures
followed for parasite culture and their species confirmation
were the same as reported elsewhere.29,30
Parasites were cultured in NovyeMacNealeNicolle (NNN)
media and were injected into BALB/c mice and retrieved
from their lymph node for preservation of their virulence.
The in vitro cultivation of parasite, after isolation from
mice, was kept to less than three passages in NNN media to
maintain their virulence. Soluble leishmanial antigens
(SLAs) were prepared as follows: L. tropica was cultivated
in liquid media consisting of Roswell Park Memorial
Institute-1640 (RPMI-1640), 10% fetal bovine serum, 1% L-
glutamine, 100 IU/mL penicillin, and 1 mg/mL strepto-
mycin. Parasites were harvested at the stationary phase of
growth curve, and washed three times with phosphate-
buffered saline (PBS). Protease inhibitor (cOmplete, Mini,
EDTA free, Roche Diagnostics, Mannheim, Germany) was
added to the parasite suspension. The parasites (concen-
tration, 2  108/mL) were subjected to 10 rounds of freeze
and thaw cycles, centrifuged at 16,000g (at 4C for 20 mi-
nutes), and the supernatant was aliquoted in small volumes
and stored at 70C until use.of IgG1 in comparison with IgG2a are associated with protective
rnal of Microbiology, Immunology and Infection (2015), http://
Figure 1. Lesion development after Leishmania tropica and
Leishmania major infection. High (106) and low (103) doses of
parasites were injected into the ear of BALB/c mice. Ear
thickness was determined at 2-week intervals. Each point is
mean þ standard deviation of values of 7e16 mice/group. The
differences were statistically significant between high doses of
L. tropica and L. major in all time points shown. Statistically
significant difference between low doses of L. tropica and L.
major were obtained from Week 14 onward.
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Female BALB/c mice (4e6 weeks old) were purchased from
the animal production facility of Pasteur Institute of Iran
(Tehran, Iran). Blood samples were obtained by the retro-
orbital bleeding procedure. The study protocol was
approved by the Ethics Committee of the Pasteur Institute
of Iran.
Infection
The parasites (10-mL volume) were intradermally injected
into the right ear of mice. The course of lesion develop-
ment was monitored by measuring ear thickness using a
dial-gauge caliper (Mitutoyo, Kawasaki, Kanagawa, Japan)
at 2-week intervals.
Study design
Mice were randomly divided into four experimental groups.
Each group consisted of 20 mice. High (106 parasites/
mouse) and low (103 parasites/mouse) doses were used for
infecting mice with both L. major and L. tropica. The
experimental groups were as follows: (1) low-dose L. major,
(2) high-dose L. major, (3) low-dose L. tropica, and (4) high-
dose L. tropica. Blood sample was obtained from four mice
in each group at three intervals after the induction of
infection (at Weeks 1, 4, and 16). Anti-Leishmania anti-
bodies of the IgG1 and IgG2a isotypes were assayed by
enzyme-linked immunosorbent assay (ELISA). The whole
experiment was carried out two times (each experiment
consisted of 80 mice) and data from one representative
experiment are presented.
Enzyme-linked immunosorbent assay
The following factors were optimized in our ELISA setting:
concentration of antigen (range, 0.2 mg/well, 0.5 mg/well,
and 1 mg/well), positive and negative serum dilutions
(range, 1/100, 1/500, and 1/1000), and dilution of horse-
radish peroxidase (HRP)-conjugated antimouse IgG1 and
IgG2a isotypes (1/1000 and 1/2000, respectively). The 96-
well ELISA plates (Greiner, MICROLON, Kremsmu¨nster,
Austria) were coated with 0.2 mg/well of SLA and incubated
at 4C overnight. The plates were then washed three times
with PBST (250 mL/well; PBS þ 0.05% v/v Tween 20) and
soaked for 1 minute in an ELISA plate washing system
(Anthos Fluido; Asys-hitech GmbH, Eugendorf, Austria).
Plates were blocked using 100 mL/well of 1% w/v bovine
serum albumin (BSA in PBS) at 37C for 2 hours. After the
washing step (as above), the sera at the 1/400 dilution
(i.e., 1 unit of each serum in 399 units of 1% w/v of BSA)
were added (100 mL/well) to plates. Plates were incubated
at 37C for 2 hours. The plates were washed as mentioned
earlier. Then, 100 mL of HRP-conjugated antimouse IgG1
(BD Pharmingen, Heidelberg, Germany) or IgG2a (BD Phar-
mingen, Heidelberg, Germany) antibodies at the 1/2000
dilution were added to the previously assigned wells, and
the plates were incubated at 37C for 2 hours. The plates
were then washed according to the method mentioned
earlier and 3,30,5,50-tetramethylbenzidine (100 mL/well) asPlease cite this article in press as: Rostamian M, et al., Lower levels
immunity against Leishmania tropica infection in BALB/c mice, Jou
dx.doi.org/10.1016/j.jmii.2015.05.007HRP substrate was added to each plate. Plates were incu-
bated at room temperature for 15 minutes in a dark place.
The enzymeesubstrate reaction was terminated by adding
a stop solution (100 mL/well; 2N H2SO4) and absorbance of
wells was read using a microplate reader (Anthos 2020;
Eugendorf, Austria) at optical densities of 620 nm and
450 nm. The final values were calculated by subtracting the
620-nm values from the 450-nm values. Each sample was
used in triplicate. Positive and negative control sera were
included in each run.
Statistical analysis
Lesion diameter, optical density (OD) of ELISA results, and
isotype ratios were compared between experimental
groups by one-tailed two-sample equal variance t test. A p
value of 0.05 or less was taken to be significant.
Results
Course of L. tropica infection in BALB/c mice
The course of infection was determined by measuring the
ear thickness. The results are shown in Figure 1. The course
of infection for L. major and L. tropica was as expected: L.
major infection, irrespective of whether a high or low dose
was injected, resulted in progressive lesions, whereas le-
sions of L. tropica infection, irrespective of the dose, dis-
played a healing pattern. Therefore, high and low doses of
both L. major and L. tropica did not change the outcome of
disease in BALB/c mice. High doses of the parasites resulted
in early onset of lesions, whereas the low doses resulted in
late onset of lesions. The results were similar to those re-
ported previously.27of IgG1 in comparison with IgG2a are associated with protective
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dilutions of sera
Three serum dilutions (1/400, 1/4000, and 1/40,000) were
used for all sera samples to validate the results. Testing of
these three serum dilutions enables the quantification of
antibody levels in sera containing high levels of antibody.
The 1/400 dilution of these titer sera containing high levels
of antibody resulted in high OD, which was not within the
assay limit of our ELISA setting, but further dilutions of
these sera yielded OD within the assay range. Data obtained
from the 1/400 dilution of sera were used for comparison of
all experimental groups, unless otherwise stated. Repre-
sentative data obtained from different dilutions of sera are
presented in Figure 2. The results showed that our ELISA
settings are reliable.
Higher parasite dose results in higher levels of
antibody
Two doses of parasites (high and low) were used for infec-
tion of mice. The antibody titer of IgG1 and IgG2a against
the high-parasite dose is significantly higher than theFigure 2. IgG1 and IgG2a levels of the three different di-
lutions of sera of mice infected with high doses of Leishmania
tropica and Leishmania major. OD Z optical density.
Please cite this article in press as: Rostamian M, et al., Lower levels
immunity against Leishmania tropica infection in BALB/c mice, Jou
dx.doi.org/10.1016/j.jmii.2015.05.007antibody titer of the same isotype against the low-parasite
dose of both species at 4 weeks and 16 weeks after the
infection. Figure 3 shows the antibody response against two
doses (high and low) of L. major and Figure 4 shows the
data for two doses (high and low) of L. tropica. These re-
sults show that antibody responses against both Leishmania
species are dependent on the infective dose and our assay
system is sufficiently optimized for detecting the differ-
ences between the low and high doses.L. tropica infection results in lower IgG1 antibody
response in comparison with L. major infection
Mice were infected with high doses of L. tropica and L.
major. The antibody responses of IgG1 and IgG2a against L.
tropica infection were lower, compared with those against
L. major infection (Figure 5). The difference in IgG1
response was statistically significant at 16 weeks after the
infection. However, the difference in IgG2a response did
not reach the significance level (pZ 0.07). When low doses
of L. tropica and L. major were used to infect the mice, the
IgG1 and IgG2a responses were quite similar to IgG1 and
IgG2a responses against the high dose of these two Leish-
mania species (Figure 6).Figure 3. Higher infective dose of Leishmania major resul-
ted in higher levels of anti-Leishmania antibody. Leishmania-
specific antibody titers are shown at indicated time points
after infection of BALB/c mice with low (103 parasites/mouse)
or high dose (106 parasites/mouse) of L. major. Antibody titers
are presented as optical density (OD). Each value is
mean þ standard deviation of values of four mice/group. The
asterisk shows statistically significant difference between the
L. major and Leishmania tropica groups (* p  0.001). The open
circle shows that the OD of each serum in this group was higher
than the assay limit at the 1/400 dilution. The 1/4000 dilution
showed OD in the assay range of the test and at this dilution
the OD of the L. major high-dose group was also higher than
that of the L. major low-dose group statistically.
of IgG1 in comparison with IgG2a are associated with protective
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Figure 4. Higher infective dose of Leishmania tropica
resulted in higher levels of anti-Leishmania antibody. Leish-
mania-specific antibody titers are shown at indicated time
points after infection of BALB/c mice with low (103 parasites/
mouse) or high dose (106 parasites/mouse) of L. tropica.
Antibody titers are presented as optical density (OD). Each
value is mean þ standard deviation of values of four mice/
group. The asterisk shows statistically significant difference
between the Leishmania major and L. tropica groups (*
p  0.001).
Figure 5. Levels of IgG2a and IgG1 in response to Leishmania
tropica and Leishmania major at high infective dose. Leish-
mania-specific antibody titers at indicated time points after
infection of BALB/c mice with a high dose (106 parasites/
mouse) of L. major or L. tropica. Antibody titers are presented
as optical density (OD). Each value is mean þ standard devia-
tion of values of four mice/group. The as terisk shows statis-
tically significant difference between the L. major and L.
tropica groups (* p  0.001). The open circle shows that the OD
of each serum in this group was higher than the assay limit at
the 1/400 dilution. The 1/4000 dilution showed OD in the assay
range of the test and at this dilution, the OD of the L. major
high-dose group was also higher than that of the L. tropica
high-dose group statistically.
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tropica and L. major infections
The levels of IgG2a and IgG1 antibodies produced against
the high doses of L. tropica and L. major are shown in
Figure 5. The data show that more IgG1 in comparison with
IgG2a is produced in response to L. major infection, but
more IgG2a in comparison with IgG1 is produced against L.
tropica infection. The amount of IgG2a/IgG1 antibodies
produced in response to L. tropica is significantly higher
than that in response to L. major at 16 weeks after the
infection. Similar results were obtained when the low doses
of L. major and L. tropica were used for infection. The
levels of IgG isotypes produced in response to low-dose
infections are presented in Figure 6. As is the case with
high-dose infection, in response to low-dose infection, the
IgG2a/IgG1 ratio is higher in L. tropica infection in com-
parison with L. major infection, and the difference was
statistically significant at 16 weeks after the infection. This
ratio (IgG2a/IgG1) does not differ significantly between
mice infected with high or low dose of L. major (Figure 7).
Similarly, for L. tropica, this ratio (IgG2a/IgG1) was not
statistically different between high and low doses of L.
tropica infection (Figure 7).
Discussion
Our findings show that the antibody response against L.
tropica infection is lower than that against L. major
infection in BALB/c mice. The different doses of parasites
(from 103 to 106/mouse) do not change the relatively lowerPlease cite this article in press as: Rostamian M, et al., Lower levels
immunity against Leishmania tropica infection in BALB/c mice, Jou
dx.doi.org/10.1016/j.jmii.2015.05.007levels of antibody produced in response to L. tropica
infection, compared with L. major.
The presence of higher levels of anti-Leishmania anti-
bodies against L. major infection in our study is concordant
with induction of Th2 response and ensuing high levels of
anti-Leishmania antibodies in response to L. major infec-
tion in BALB/c mice.28 Lower levels of anti-Leishmania
antibodies produced against L. tropica infection suggest
that the Th2 response is lower against L. tropica infection
in comparison with L. major infection in BALB/c mice.
Our results show that higher levels of Leishmania-spe-
cific IgG1 antibodies are associated with increasing thick-
nesses of lesions in BALB/c mice (i.e., IgG1 is associated
with progressive leishmaniasis). These findings are similar
to other reports.17,19,31 The levels of IgG1 anti-Leishmania
antibodies produced in response to L. tropica infection are
lower than those produced in response to L. major. This is
an important difference with regard to the immune
response against these two Leishmania species. This in-
dicates that the IgG1 isotype of anti-Leishmania antibodies
is associated with disease exacerbation and lower levels of
this isotype is associated with protection against the dis-
ease in BALB/c mice. These findings are consistent with
other reports regarding L. major infection.17,19,31 These
data suggest that the IgG1 isotype of anti-Leishmania an-
tibodies has a detrimental role, and that lower levels ofof IgG1 in comparison with IgG2a are associated with protective
rnal of Microbiology, Immunology and Infection (2015), http://
Figure 6. Levels of IgG2a and IgG1 in response to Leishmania
tropica and Leishmania major at low infective dose. Leish-
mania-specific antibody titers at indicated time points after
infection of BALB/c mice with a low dose (103 parasites/
mouse) of L. major or L. tropica. Antibody titers are presented
as optical density (OD). Each value is mean þ standard devia-
tion of values of four mice/group. The asterisk shows statisti-
cally significant difference between the L. major and L. tropica
groups (* p  0.05).
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tropica infection.
The ratio of IgG2a to IgG1 shows the combined effect of
IgG2a and IgG1. Our results show that there is a sharp dif-
ference in this ratio between L. tropica and L. major in-
fections. The IgG2a level is higher than that of IgG1 inFigure 7. The IgG2a/IgG1 ratio in response to Leishmania
tropica and Leishmania major infection in BALB/c mice. The
differences were statistically significant at 16 weeks after
infection between L. tropica and L. major at both high and low
doses.
Please cite this article in press as: Rostamian M, et al., Lower levels
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dx.doi.org/10.1016/j.jmii.2015.05.007response to L. tropica (i.e., IgG2a/IgG1 ratio > 1). How-
ever, the IgG1 level is higher than that of IgG2a in response
to L. major (i.e., IgG2a/IgG1 ratio < 1). These data suggest
that the protective immune response against L. tropica
needs not only a low level of IgG1, but also a high level of
IgG2a, compared with IgG1. It is possible that the IgG2a
response has a beneficial effect and that the IgG1 response
counteracts its effects. The beneficial effect of IgG2a
response may occur only when the IgG1 response
diminishes.
Our findings clearly show that higher levels of IgG2a,
compared with IgG1, are associated with beneficial effects
in L. tropica-infected BALB/c mice. This is the first report
on L. tropica infection. These findings are consistent with
those of other reports that a higher ratio of the IgG2a/IgG1
isotype is associated with a protective immunity against L.
major infection in BALB/c mice, irrespective of whether
the healing resulted from low doses of parasites17,19 or the
healing resulted from vaccination.18,20e23 Therefore, our
findings on L. tropica infection in BALB/c mice in addition
to other reports suggest that high levels of IgG2a and low
levels of IgG1 isotype of anti-Leishmania antibodies in this
in-bred mice strain are associated with protective immunity
against different Leishmania species, at least for L. trop-
ica, L. major,19 and Leishmania donovani.23
In summary, we conclude that higher IgG2a/IgG1 ratio is
associated with protective immune response in L. tropica
infection. These data can help to approach the complex
profile of immunity against L. tropica infection.
Conflicts of interest
All contributing authors declare no conflicts of interest.
Acknowledgments
This research was supported by the Pasteur Institute of Iran
(Grant No. 595).
References
1. World Health Organization. Control of the leishmaniases:
report of a Meeting of the WHO Expert Committee on the
Control of Leishmaniases. Geneva, Switzerland: WHO Tech-
nical Report Series; 2010.
2. Sacks DL. B cell dependent T lymphocyte responses in leish-
maniasis. Mem Inst Oswaldo Cruz 1988;83:506e13.
3. Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g sub-
class activity through selective Fc receptor binding. Science
2005;310:1510e2.
4. Sacks DL, Scott PA, Asofsky R, Sher FA. Cutaneous leishmaniasis
in anti-IgM-treated mice: enhanced resistance due to func-
tional depletion of a B cell-dependent T cell involved in the
suppressor pathway. J Immunol 1984;132:2072e7.
5. Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM. A role
for IgG immune complexes during infection with the intracel-
lular pathogen Leishmania. J Exp Med 2005;201:747e54.
6. Sutterwala FS, Noel GJ, Salgame P, Mosser DM. Reversal of
proinflammatory responses by ligating the macrophage Fc
gamma receptor type I. J Exp Med 1998;188:217e22.
7. Padigel UM, Farrell JP. Control of infection with Leishmania
major in susceptible BALB/c mice lacking the common gamma-of IgG1 in comparison with IgG2a are associated with protective
rnal of Microbiology, Immunology and Infection (2015), http://
IgG isotypes in Leishmania tropica infection 7
+ MODELchain for FcR is associated with reduced production of IL-10 and
TGF-beta by parasitized cells. J Immunol 2005;174:6340e5.
8. Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C,
Verbeek S, et al. Uptake of Leishmania major by dendritic cells
is mediated by Fc gamma receptors and facilitates acquisition
of protective immunity. J Exp Med 2006;203:177e88.
9. Fahey JL, Wunderlich J, Mishell R. The immunoglobulins of
mice. I. Four major classes of immunoglobulins: 7Sg2-, 7Sg1-,
g1A(b2A)-, and 18S g1M-globulins. J Exp Med 1964;120:223e42.
10. Fahey JL, Wunderlich J, Mishell R. The immunoglobulins of
mice. II. Two subclasses of mouse 7Sg2-globulins: g2a-and g2b-
globulins. J Exp Med 1964;120:243e51.
11. Nussenzweig RS, Merryman C, Benacerraf B. Electrophoretic
separation and properties of mouse antihapten antibodies
involved in passive cutaneous anaphylaxis and passive hemo-
lysis. J Exp Med 1964;120:315e28.
12. Grey HM, Hirst JW, Cohn M. A new mouse immunoglobulin:
IgG3. J Exp Med 1971;133:289e304.
13. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory
factor-1 reciprocally regulate Ig isotype production. Science
1987;236:944e7.
14. Finkelman FD, Holmes J, Katona IM, Urban Jr JF, Beckmann MP,
Park LS, et al. Lymphokine control of in vivo immunoglobulin
isotype selection. Annu Rev Immunol 1990;8:303e33.
15. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4þ
effector cells default to the Th2 pathway in interferon gamma-
deficient mice infected with Leishmania major. J Exp Med
1994;179:1367e71.
16. Fox CB, Sivananthan SJ, Duthie MS, Vergara J, Guderian JA,
Moon E, et al. A nanoliposome delivery system to synergisti-
cally trigger TLR4 and TLR7. J Nanobiotechnology 2014;12:17.
17. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Estab-
lishment of stable, cell-mediated immunity that makes “sus-
ceptible” mice resistant to Leishmania major. Science 1992;
257:539e42.
18. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Ro¨cken M,
Wagner H, et al. CpG oligodeoxynucleotides trigger protective
and curative Th1 responses in lethal murine leishmaniasis. J
Immunol 1998;160:3627e30.
19. Uzonna JE, Wei G, Yurkowski D, Bretscher P. Immune elimi-
nation of Leishmania major in mice: Implications for immune
memory, vaccination, and reactivation disease. J Immunol
2001;167:6967e74.
20. Yamakami K, Akao S, Sato M, Nitta Y, Miyazaki J, Tadakuma T.
A single intradermal administration of soluble leishmanial an-
tigen and plasmid expressing interleukin-12 protects BALB/cPlease cite this article in press as: Rostamian M, et al., Lower levels
immunity against Leishmania tropica infection in BALB/c mice, Jou
dx.doi.org/10.1016/j.jmii.2015.05.007mice from Leishmania major infection. Parasitol Int 2001;50:
81e91.
21. Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT,
Mahboudi F, et al. Immune response and protection assay of
recombinant major surface glycoprotein of Leishmania (rgp63)
reconstituted with liposomes in BALB/c mice. Vaccine 2006;24:
5708e17.
22. Shimizu Y, Takagi H, Nakayama T, Yamakami K, Tadakuma T,
Yokoyama N, et al. Intraperitoneal immunization with
oligomannose-coated liposome-entrapped soluble leishmanial
antigen induces antigen-specific T-helper type immune
response in BALB/c mice through uptake by peritoneal mac-
rophages. Parasite Immunol 2007;29:229e39.
23. Thakur A, Kaur H, Kaur S. Evaluation of the immunoprophy-
lactic potential of a killed vaccine candidate in combination
with different adjuvants against murine visceral leishmaniasis.
Parasitol Int 2015;64:70e8.
24. Chu N, Thomas BN, Patel SR, Buxbaum LU. IgG1 is pathogenic in
Leishmania mexicana infection. J Immunol 2010;185:6939e46.
25. Sacks DL, Melby PC. Animal models for the analysis of immune
responses to leishmaniasis. Curr Protoc Immunol 1998. John
Wiley & Sons, New York, 19.2.1e19.2.20.
26. Lira R, Me´ndez S, Carrera L, Jaffe C, Neva F, Sacks D. Leish-
mania tropica: the identification and purification of metacyclic
promastigotes and use in establishing mouse and hamster
models of cutaneous and visceral disease. Exp Parasitol 1998;
89:331e42.
27. Mahmoudzadeh-Niknam H. Induction of partial protection
against Leishmania major in BALB/c mice by Leishmania
tropica. Scand J Lab Anim Sci 2004;31:201e7.
28. Sacks D, Noben-Trauth N. The immunology of susceptibility and
resistance to Leishmania major in mice. Nat Rev Immunol
2002;2:845e58.
29. Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. Protective im-
munity against Leishmania major induced by Leishmania
tropica infection of BALB/c mice. Exp Parasitol 2011;127:
448e53.
30. Mahmoudzadeh-Niknam H, Abrishami F, Doroudian M,
Moradi M, Alimohammadian MH, Parvizi P, et al. The problem
of mixing up of Leishmania isolates in the laboratory: sugges-
tion of ITS1 gene sequencing for verification of species. Iran J
Parasitol 2011;6:41e8.
31. Morris L, Troutt AB, McLeod KS, Kelso A, Handman E,
Aebischer T. Interleukin-4 but not gamma interferon produc-
tion correlates with the severity of murine cutaneous leish-
maniasis. Infect Immun 1993;61:3459e65.of IgG1 in comparison with IgG2a are associated with protective
rnal of Microbiology, Immunology and Infection (2015), http://
